A cardiac defibrillation system that includes a pulse generator to generate therapeutic electrical pulses and at least one lead inserted through an intercostal space in the region of a cardiac notch of the left lung of a patient, the lead having a distal end configured to transmit the therapeutic electrical pulses generated by the pulse generator to defibrillate the heart of the patient.

VfA cardiac therapy uses an implantable medical device or system. The implantable medical device includes a tissue-piercing electrode implanted in the basal and/or septal region of the left ventricular myocardium of the patient's heart from the triangle of Koch region of the right atrium through the right atrial endocardium and central fibrous body. The device may include a right atrial electrode, a right atrial motion detector, or both. The device may be implanted completely within the patient's heart or may use one or more leads to implant electrodes in the patient's heart. The device may be used to provide cardiac therapy, including single or multiple chamber pacing, atrioventricular synchronous pacing, asynchronous pacing, triggered pacing, cardiac resynchronization pacing, or tachycardia-related therapy. A separate medical device may be used to provide some functionality for cardiac therapy, such as sensing, pacing, or shock therapy.

A system and method for accelerating confirmation of cardiac arrhythmias is provided. The system includes memory to store specific executable instructions. One or more processors are configured to execute the specific executable instructions for obtaining a far field cardiac activity (CA) data set that includes far field CA signals for a series of beats. The CA data set includes a first CA data subset and a remainder CA data subset. The system analyzes the CA data set for an arrhythmia of interest utilizing a primary detection process having primary criteria. During a first phase of the primary detection process the system analyzes the first CA data subset to determine whether the first CA data subset satisfies at least a portion of the primary criteria. When the first CA data subset satisfies at least the portion of the primary criteria, the system initiates a secondary confirmation process. Parallel and contemporaneous in time the system i) analyzes the first CA data subset utilizing secondary criteria associated with the secondary confirmation process and ii) analyzes the remainder CA data subset utilizing the primary criteria. The system declares the CA data set to exhibit an arrhythmia episode when the first CA data subset satisfies the secondary criteria and the remainder CA data subset satisfies a remainder of the primary criteria.

A lead delivery system having a base for securing a lead delivery device to one or more anatomical structures of a patient and a lead advancer configured to incrementally advance a lead into a patient by a predefined amount.

Systems, methods and devices for delivering stimulating energy with a lead are disclosed. One method includes inserting a lead for cardiac therapy into an intercostal space of a patient and proximate to a lateral margin of the patient's sternum (the lead having a distal end configured to transmit therapeutic electrical pulses from a pulse generator to the heart), advancing the distal end of the lead through the intercostal space, and coupling a proximal end of the lead to the pulse generator for delivery of therapeutic electrical pulses for pacing or defibrillation of the heart.

A leadless pacemaker device configured to provide for an intra-cardiac pacing includes a processing circuitry configured to generate ventricular pacing signals for stimulating ventricular activity at a ventricular pacing rate and a sensor configuration configured to receive a sense signal over a multiplicity of heart cycles. The processing circuitry is configured to derive, from signal portions of the sense signal relating to the multiplicity of heart cycles, a combined signal portion and to analyze the combined signal portion for obtaining information relating to an atrial event. The processing circuitry is configured to sum a predefined number of signal portions relating to different heart cycles to obtain the combined signal portion. The leadless pacemaker device allows, in particular, for a reliable detection of signals relating to an atrial activity and the use of such signals for controlling a ventricular pacing rate for a ventricular pacing.

Delivery devices, systems, and methods for delivering implantable leadless pacing devices are disclosed. An example delivery device may an outer tubular member and an inner tubular member slidably disposed within the lumen of the outer tubular member. A distal holding section may extend distally of a distal end of the inner tubular member and define a cavity therein for receiving an implantable leadless pacing device. The device may further include a hub portion including at least a first hub portion affixed adjacent to the proximal end of the outer tubular member and a second hub portion affixed adjacent to the proximal end of the inner tubular member. A first locking mechanism configured to releasably couple the outer tubular member and the inner tubular member may be disposed within the hub portion.

Embodiments of the present disclosure provide for catheters for use in electrical neuromodulation. The catheter of the present disclosure includes an elongate body having a first end and a second end. The elongate body includes a longitudinal center axis that extends between the first end and the second end. The elongate body further includes three or more surfaces that define a convex polygonal cross-sectional shape taken perpendicularly to the longitudinal center axis. The catheter further includes one or more electrodes on one surface of the three or more surfaces of the elongate body, where conductive elements extend through the elongate body. The conductive elements can conduct electrical current to combinations of the one or more electrodes.

Methods, systems and devices for providing cardiac resynchronization therapy (CRT) to a patient using a leadless cardiac pacemaker (LCP) implanted in or proximate the left ventricle of a patient. A setup phase is used to establish parameters in the therapy delivery. In operation, the method and/or device will sense at least one non-paced cardiac cycle to determine a native R-R interval, and then delivers a synchronization pace at an interval less than the native R-R interval followed by a plurality of pace therapies delivered at the R-R interval or a modification thereof.

A system and method for improving heart contractions during a heart function cycle (heartbeat) of a patient requires detecting a local electrical event (depolarization) during the cycle. This local electrical event is then used to trigger a stimulation interval t at a time t.sub.0. Importantly, the stimulation interval t is set to end at a time t.sub.1 during the absolute refractory period of the heart function cycle. At the time t.sub.1, a stimulator is triggered to stimulate a local sympathetic nerve on the epicardial surface of the heart. With this stimulation the sympathetic nerve secretes norepinephrine to improve a subsequent contraction of the heart.